Pharmacogenetic Testing of Patients With Unwanted Adverse Drug Reactions or Therapy Failure

Recruiting now

Conditions studied: Adverse Drug Reaction, Therapy Failure

In brief

Genetic makeup of a patient influences the efficacy and safety profile of a drug. This study is to summarize individual cases, where Pharmacogenetics (PGx) has been applied during pharmaceutical care. The primary objective is the compilation of case reports, where pharmacogenetic testing is applied to determine the hereditable component of the patient's susceptibility to experience therapy failure and/or adverse drug reactions. The experience with the compiled cases will be basis for the development of a reliable standard of procedure for pharmacogenetic testing in the community pharmacy. The cases will be supplemented with information on additional Parameters reported in the literature to affect efficacy or safety of the respective drug.

Key facts

Study ID
NCT04154553
Run by
University Hospital, Basel, Switzerland
People needed
400
Starts
2019-10-15
Expected to finish
2026-08-01
Last updated by the study team
2025-05-14

Who can join

Age: 2 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.